News and Events

September is National Childhood Cancer Awareness Month, a time dedicated to raising awareness and supporting children and families affected by this devastating disease. Eurofins Viracor is proud to be at the forefront of pediatric cancer testing, offering advanced diagnostic solutions to improve outcomes for children battling leukemia. Our ExPeCT^TM CAR T test plays a crucial role in monitoring pediatric CAR T-cell therapy...

Come visit us at the conference! We will be exhibiting at IDWeek 2023 - October 11-15th, booth #2219 Boston Convention & Exhibition Center Stop by the Eurofins Vircaor booth to chat with us, explore case studies, attend in-booth presentations, and so much more! ...

When it comes to CAR T-cell therapy for pediatric patients, several factors need to be considered during laboratory testing to ensure optimal treatment outcomes. These considerations include the unique biological characteristics of pediatric patients, the specific types of cancers prevalent in this population, and the potential impact of prior treatments. While CAR T-cell therapy offers promising outcomes...

Comprehensive CMV testing is a crucial tool in the management of cytomegalovirus infections. It enables early diagnosis, facilitates appropriate treatment interventions, and aids in optimizing patient outcomes. By implementing comprehensive CMV testing protocols, healthcare providers can effectively assess, treat, and manage CMV infections, ultimately improving the quality of care for affected individuals...

Invasive fungal diseases (IFDs) are a serious and often life-threatening group of infections caused by fungi that invade tissues and organs. These infections can be serious and even fatal, especially in people who are immunocompromised. These diseases are becoming increasingly common, especially in people with weakened immune systems due to diseases such as HIV/AIDS, cancer, and organ transplantation...

With Illumina Connected Analytics, Eurofins Viracor can now analyze complex data sets, freeing them up to make greater discoveries Around the world, sequencing laboratories are experiencing an increase in the demand for clinical next-generation sequencing (NGS). But with that demand comes the possibility of a bioinformatics bottleneck. No one understands this more than Eurofins ...

CAR T-cell therapy is a promising new approach to treating cancer. CAR T-cell therapy stands for chimeric antigen receptor T-cell therapy. It involves taking a patient's T-cells, a type of immune cell, and genetically modifying those T-cells to recognize and attack cancer cells. This is done by adding a chimeric antigen receptor (CAR) to the T-cells. This therapy has shown remarkable success in treating certain types of blood cancers...

Join us for an innovative discussion on how Eurofins Transplant Diagnostics is elevating transplant care for recipients. Learn about TruGraf Kidney, the only non-invasive biomarker test validated for surveillance of stable kidney transplant recipients, and Viracor TRAC, a non-invasive alternative to biopsies to evaluate acute allograft rejection, and CMV inSIGHT and its focus on new diagnostics and therapeutics.

Eurofins Viracor ExPeCT™ CAR-T multiplexed quantitative real-time PCR (qPCR) assay provides a powerful diagnostic tool to monitor and optimize CAR-T therapy...

PRODUCT THEATER PRESENTATION:BK Polyomavirus and Thrombotic Microangiopathy After Stem Cell Transplant: Current Knowledge and Unmet NeedsWHEN: February 19th, 2023, 12:15 p.m. -1:15 p.m.WHERE: Product and Innovation Theater 1 (PIT Room 1)WHO: Dr. Ben Laskin Dr. Sonata Jodele Dr. Steve Kleiboeker Dr. Ben LaskinBenjamin Laskin, MD, is Chief of the Division of Nephrology and an a ...